BG47033A3 - Method for preparing of derivatives of imidazolamine - Google Patents
Method for preparing of derivatives of imidazolamineInfo
- Publication number
- BG47033A3 BG47033A3 BG068328A BG6832885A BG47033A3 BG 47033 A3 BG47033 A3 BG 47033A3 BG 068328 A BG068328 A BG 068328A BG 6832885 A BG6832885 A BG 6832885A BG 47033 A3 BG47033 A3 BG 47033A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- imidazolamine
- derivatives
- preparing
- antihistamine
- pharmaceuticals
- Prior art date
Links
- DEPDDPLQZYCHOH-UHFFFAOYSA-N 1h-imidazol-2-amine Chemical class NC1=NC=CN1 DEPDDPLQZYCHOH-UHFFFAOYSA-N 0.000 title 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 229940124623 antihistamine drug Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Electric Propulsion And Braking For Vehicles (AREA)
- Dc Digital Transmission (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Gas Separation By Absorption (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56911584A | 1984-01-09 | 1984-01-09 | |
| US06/660,670 US4588722A (en) | 1984-01-09 | 1984-10-15 | N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG47033A3 true BG47033A3 (en) | 1990-04-16 |
Family
ID=27074987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG068328A BG47033A3 (en) | 1984-01-09 | 1985-01-09 | Method for preparing of derivatives of imidazolamine |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4588722A (es) |
| EP (1) | EP0151824B1 (es) |
| KR (1) | KR870001046B1 (es) |
| AT (1) | ATE51621T1 (es) |
| AU (1) | AU575612B2 (es) |
| BG (1) | BG47033A3 (es) |
| CA (1) | CA1246070A (es) |
| DE (1) | DE3481841D1 (es) |
| DK (1) | DK8885A (es) |
| ES (1) | ES8604203A1 (es) |
| FI (1) | FI83781C (es) |
| GR (1) | GR850059B (es) |
| HU (1) | HU196389B (es) |
| IE (1) | IE57968B1 (es) |
| IL (1) | IL74017A (es) |
| MA (1) | MA20322A1 (es) |
| NO (1) | NO850084L (es) |
| NZ (1) | NZ210675A (es) |
| PH (1) | PH21554A (es) |
| PT (1) | PT79808B (es) |
| RO (1) | RO91075B (es) |
| SU (1) | SU1400509A3 (es) |
| ZW (1) | ZW585A1 (es) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0144101B1 (en) * | 1983-11-30 | 1991-02-06 | Janssen Pharmaceutica N.V. | Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines |
| US4839374A (en) * | 1984-01-09 | 1989-06-13 | Janssen Pharmaceutica, N.V. | 4-((Bicyclic heterocyclyl)-methyl and -hetero)-piperidines |
| PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
| DE3563964D1 (en) * | 1984-10-16 | 1988-09-01 | Synthelabo | Piperidine derivatives, their preparation and their therapeutical application |
| GB8515934D0 (en) * | 1985-06-24 | 1985-07-24 | Janssen Pharmaceutica Nv | (4-piperidinomethyl and-hetero)purines |
| FR2587029B1 (fr) * | 1985-09-11 | 1987-10-30 | Synthelabo | Derives de benzimidazole, leur preparation et leur application en therapeutique |
| ATE79620T1 (de) * | 1986-02-03 | 1992-09-15 | Janssen Pharmaceutica Nv | N-heterozyklische-4-piperidinamine enthaltende anti-histaminische zusammensetzungen. |
| NZ223654A (en) * | 1987-03-09 | 1990-03-27 | Janssen Pharmaceutica Nv | 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions |
| US4943580A (en) * | 1987-03-09 | 1990-07-24 | Janssen Pharmaceutica N.V. | Anti-histaminic benzimidazole, imidazopyridine and purine derivatives |
| US4897401A (en) * | 1987-06-19 | 1990-01-30 | Janssen Pharmaceutical N.V. | N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases |
| US5006527A (en) * | 1987-06-19 | 1991-04-09 | Janssen Pharmaceutica N.V. | Pharmacologically active N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives |
| CA1317939C (en) * | 1987-07-01 | 1993-05-18 | Janssen Pharmaceutica Naamloze Vennootschap | ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines |
| US4988689A (en) * | 1987-07-01 | 1991-01-29 | Janssen Pharmaceutica N.V. | ((Pharmacologically active bicyclic heterocyclic)methyl and -heteroatom) substituted hexahydro-1H-azepines and pyrrolidines |
| GB8900380D0 (en) * | 1989-01-09 | 1989-03-08 | Janssen Pharmaceutica Nv | 2-aminopyrimidinone derivatives |
| US5272150A (en) * | 1989-04-07 | 1993-12-21 | Janssen Pharmaceutica N.V. | Hydroxyalkylfuranyl derivatives |
| PH30434A (en) * | 1989-04-07 | 1997-05-09 | Janssen Pharmaceutica Nv | Hydroxyalkylfuranyl derivatives |
| NZ238863A (en) * | 1990-07-19 | 1993-03-26 | Janssen Pharmaceutica Nv | Substituted thiazolyl and pyridinyl derivatives |
| KR100190299B1 (ko) * | 1990-07-19 | 1999-06-01 | 디르크 반테 | 신규한 옥사졸릴 유도체 |
| DE4129603A1 (de) * | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| EP0699668A4 (en) * | 1993-05-20 | 1996-09-18 | Kissei Pharmaceutical | DERIVATIVE 1- (2-BENZIMIDAZOLYL) -1,5-DIAZACYCLOOCTANE |
| TW531537B (en) | 1995-12-27 | 2003-05-11 | Janssen Pharmaceutica Nv | 1-(1,2-disubstituted piperidinyl)-4-substituted piperidine derivatives |
| US5922737A (en) * | 1996-02-21 | 1999-07-13 | Hoechst Marion Roussel, Inc. | Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases |
| TW527186B (en) * | 1996-03-19 | 2003-04-11 | Janssen Pharmaceutica Nv | Fused imidazole derivatives as multidrug resistance modulators |
| US5817823A (en) * | 1997-04-17 | 1998-10-06 | Sepracor Inc. | Method for synthesizing 2-substituted imidazoles |
| ES2228559T3 (es) | 1999-06-28 | 2005-04-16 | Janssen Pharmaceutica N.V. | Inhibidores de la replicacion del virus respiratorio sincintial. |
| MXPA02000120A (es) | 1999-06-28 | 2002-07-02 | Janssen Pharmaceutica Nv | Inhibidores de la replicacion del virus sincitial respiratorio. |
| JP2003503403A (ja) | 1999-06-28 | 2003-01-28 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 呼吸合胞体ウイルス複製阻害剤 |
| AR033517A1 (es) * | 2000-04-08 | 2003-12-26 | Astrazeneca Ab | Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos |
| JP2001302635A (ja) * | 2000-04-21 | 2001-10-31 | Suntory Ltd | 新規複素環化合物 |
| RU2004100839A (ru) | 2001-07-02 | 2005-06-20 | Астразенека Аб (Se) | Производные пиперидина полезные в качестве модуляторов активности рецепторов хемокинов |
| GB0120461D0 (en) | 2001-08-22 | 2001-10-17 | Astrazeneca Ab | Novel compounds |
| AR036366A1 (es) | 2001-08-29 | 2004-09-01 | Schering Corp | Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit |
| GB0122503D0 (en) | 2001-09-18 | 2001-11-07 | Astrazeneca Ab | Chemical compounds |
| WO2003059965A1 (en) * | 2002-01-10 | 2003-07-24 | University Of Washington | Hydrogels formed by non-covalent linkages |
| SE0200843D0 (sv) * | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0200844D0 (sv) * | 2002-03-19 | 2002-03-19 | Astrazeneca Ab | Chemical compounds |
| SE0202838D0 (sv) * | 2002-09-24 | 2002-09-24 | Astrazeneca Ab | Chemical compounds |
| SE0300850D0 (sv) * | 2003-03-25 | 2003-03-25 | Astrazeneca Ab | Chemical compounds |
| SE0300957D0 (sv) * | 2003-04-01 | 2003-04-01 | Astrazeneca Ab | Chemical compounds |
| SE0400925D0 (sv) * | 2004-04-06 | 2004-04-06 | Astrazeneca Ab | Chemical compounds |
| BRPI0608847A2 (pt) | 2005-03-08 | 2010-02-02 | Janssen Pharmaceutica Nv | derivados de diaza-espiro-[4,4]-nonano substituìdos e seu uso como antagonistas de neurocinina |
| TW200722419A (en) * | 2005-05-27 | 2007-06-16 | Astrazeneca Ab | Chemical compounds |
| WO2006126948A1 (en) * | 2005-05-27 | 2006-11-30 | Astrazeneca Ab | Piperidines for the treatment of chemokine mediated diseases |
| KR20080037655A (ko) * | 2005-07-21 | 2008-04-30 | 아스트라제네카 아베 | 신규 피페리딘 유도체 |
| CN104910894B (zh) * | 2015-05-05 | 2017-05-03 | 山东大学 | 一种苯并咪唑类hERG钾离子通道的小分子荧光探针及其制备方法与应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2971005A (en) * | 1958-10-17 | 1961-02-07 | Merck & Co Inc | Nu-substituted derivatives of 2-benzylaminobenzimidazoles |
| GB1260857A (en) * | 1968-07-10 | 1972-01-19 | Hexachimie | IMIDAZO-3H-(4,5-b)-PYRIDINE DERIVATIVES |
| BE788065A (fr) * | 1971-08-26 | 1973-02-26 | Degussa | Nouvelles aza-benzimidazoles et procede pour leur preparation |
| US4219559A (en) * | 1979-01-10 | 1980-08-26 | Janssen Pharmaceutica N.V. | N-Heterocyclyl-4-piperidinamines |
| US4634704A (en) * | 1983-10-06 | 1987-01-06 | Janssen Pharmaceutica, N.V. | Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines |
| EP0144101B1 (en) * | 1983-11-30 | 1991-02-06 | Janssen Pharmaceutica N.V. | Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines |
| PH23995A (en) * | 1984-01-09 | 1990-02-09 | Janssen Pharmaceutica Nv | 4((bicycle heterocyclyl)-methyl and hetero)piperidines |
-
1984
- 1984-10-15 US US06/660,670 patent/US4588722A/en not_active Expired - Fee Related
- 1984-11-02 PH PH31396A patent/PH21554A/en unknown
- 1984-12-04 CA CA000469245A patent/CA1246070A/en not_active Expired
- 1984-12-06 EP EP84201812A patent/EP0151824B1/en not_active Expired - Lifetime
- 1984-12-06 AT AT84201812T patent/ATE51621T1/de not_active IP Right Cessation
- 1984-12-06 DE DE8484201812T patent/DE3481841D1/de not_active Expired - Fee Related
- 1984-12-20 NZ NZ210675A patent/NZ210675A/en unknown
- 1984-12-29 KR KR1019840008561A patent/KR870001046B1/ko not_active IP Right Cessation
- 1984-12-31 ES ES539266A patent/ES8604203A1/es not_active Expired
-
1985
- 1985-01-07 AU AU37363/85A patent/AU575612B2/en not_active Ceased
- 1985-01-07 RO RO117231A patent/RO91075B/ro unknown
- 1985-01-08 MA MA20546A patent/MA20322A1/fr unknown
- 1985-01-08 PT PT79808A patent/PT79808B/pt unknown
- 1985-01-08 DK DK8885A patent/DK8885A/da not_active Application Discontinuation
- 1985-01-08 IL IL74017A patent/IL74017A/xx unknown
- 1985-01-08 ZW ZW5/85A patent/ZW585A1/xx unknown
- 1985-01-08 NO NO850084A patent/NO850084L/no unknown
- 1985-01-08 IE IE41/85A patent/IE57968B1/en not_active IP Right Cessation
- 1985-01-08 FI FI850078A patent/FI83781C/fi not_active IP Right Cessation
- 1985-01-08 HU HU8562A patent/HU196389B/hu not_active IP Right Cessation
- 1985-01-09 GR GR850059A patent/GR850059B/el unknown
- 1985-01-09 BG BG068328A patent/BG47033A3/xx unknown
- 1985-10-08 SU SU853838812A patent/SU1400509A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| IL74017A0 (en) | 1985-04-30 |
| NO850084L (no) | 1985-07-10 |
| DK8885A (da) | 1985-07-10 |
| PT79808B (en) | 1987-01-07 |
| KR870001046B1 (ko) | 1987-05-26 |
| DE3481841D1 (de) | 1990-05-10 |
| EP0151824A3 (en) | 1985-10-09 |
| ZW585A1 (en) | 1986-07-30 |
| GR850059B (es) | 1985-01-11 |
| AU575612B2 (en) | 1988-08-04 |
| FI83781B (fi) | 1991-05-15 |
| US4588722A (en) | 1986-05-13 |
| HUT37780A (en) | 1986-02-28 |
| IE57968B1 (en) | 1993-06-03 |
| FI83781C (fi) | 1991-08-26 |
| MA20322A1 (fr) | 1985-10-01 |
| FI850078A0 (fi) | 1985-01-08 |
| ES539266A0 (es) | 1986-01-16 |
| RO91075A (ro) | 1987-02-27 |
| KR850005437A (ko) | 1985-08-26 |
| EP0151824B1 (en) | 1990-04-04 |
| ATE51621T1 (de) | 1990-04-15 |
| IL74017A (en) | 1988-03-31 |
| IE850041L (en) | 1985-07-09 |
| AU3736385A (en) | 1985-08-01 |
| CA1246070A (en) | 1988-12-06 |
| HU196389B (en) | 1988-11-28 |
| FI850078L (fi) | 1985-07-10 |
| EP0151824A2 (en) | 1985-08-21 |
| ES8604203A1 (es) | 1986-01-16 |
| DK8885D0 (da) | 1985-01-08 |
| RO91075B (ro) | 1987-02-28 |
| SU1400509A3 (ru) | 1988-05-30 |
| PH21554A (en) | 1987-12-11 |
| NZ210675A (en) | 1987-05-29 |
| PT79808A (en) | 1985-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG47033A3 (en) | Method for preparing of derivatives of imidazolamine | |
| SE8602723D0 (sv) | Thiazoles, their production and pharmaceutical compositions containing them | |
| NL193981B (nl) | 7-(eventueel gesubstitueerd naftyl)-3-methyl-octa-2,4,6-trieenderivaten met retineachtige werking alsmede farmaceutische en kosmetische preparaten die dergelijke derivaten bevatten. | |
| DE3675169D1 (de) | Herstellung von tabletten. | |
| ATE111452T1 (de) | Tetrahydronaphthalin- und indanderivate, deren herstellung und verwendung für pharmazeutische präparate. | |
| DE3669104D1 (de) | Pharmazeutische praeparate, die ascorbinsaeurederivate enthalten. | |
| DE3580616D1 (de) | Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| IT1237472B (it) | Derivati di acido 3-indolpiruvico, loro procedimento di produzione ed impiego terapeutico. | |
| NO160369C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive 1,3-dihydro-6-(1-hydroksy-2-dimetylaminometyl-allyl)-7-hydroksy-furo(3,4-c)-pyridinderivater. | |
| DK53285D0 (da) | (-)-trans-4(4-fluorphenyl)-3-(4-methoxyphenoxy)-methylpiperidin, farmaceutisk acceptable syreadditionssalte heraf og farmaceutisk praeparat indeholdende samme | |
| DK314887D0 (da) | Kompleksforbindelser, farmaceutiske midler med indhold heraf samt fremgangsmaade til fremstilling heraf | |
| NL190520B (nl) | Op plaats 1 gesubstitueerde, 7-gesubstitueerde amino-6-halogeen-4-oxo-1,4-dihydrochinoline-3-carbonzuren en farmaceutische preparaten, die deze bevatten. | |
| NL8601837A (nl) | Poly-4-aminopyrrool-2-carboxamidoderivaten, werkwijze ter bereiding ervan, farmaceutische preparaten, die deze derivaten bevatten alsmede werkwijze voor de bereiding van de farmaceutische preparaten. | |
| BG43693A3 (en) | Method for preparing of 6, 16- dimethylcorticoids | |
| FI91964C (fi) | Menetelmä uusien, farmaseuttisesti aktiivisten 1-(hydroksistyryyli)-5H-2,3-bentsodiatsepiinijohdannaisten valmistamiseksi | |
| NO165545C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater. | |
| NO870998L (no) | Fremgangsmte for fremstilling av nye, terapeutisk aktive acetamid-derivater. | |
| NO872778L (no) | Nye 4-pyridonderivater samt fremgangsmte for fremstilling derav. | |
| DK165951C (da) | Imidazolderivater, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse | |
| DK77588A (da) | Prostaglandin e1-derivater og farmaceutiske praeparater, der indeholder dem | |
| BG44379A3 (en) | Method for preparing of 9- chlor- 1, 5- benzothiazepine derivatives | |
| NL192520B (nl) | Gesubstitueerde tetrahydrofuranderivaten met anti-PAF-werking, werkwijze voor hun bereiding en farmaceutische preparaten die hen bevat. | |
| AU7679987A (en) | New (benzofuran-2-yl) imidazoles having pharmaceutical activity, their salts and relevant production processes | |
| ATE32882T1 (de) | Phenylnonatetraensaeurederivate, ihre herstellung und pharmazeutische praeparate mit diesen derivaten. | |
| DE3586952D1 (de) | Fibrinophiler urokinase-komplex und dessen herstellung. |